(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MAVANCLAD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MAVANCLAD

ST13

US500000079207880

Class

5

Filing

79207880

Registration

5314424

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

05/14/2025

Trademark type

Word

Nice classes

5

Filing date

01/18/2017

Registration date

10/24/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/10/2024

Last transaction

05/14/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

31

Owner location

DE

Examiner

TENG, SIMON

Law office

L50

Current location

PETITIONS OFFICE

Holders and representatives

Holders

Merck KGaA

Representatives

William C. Wright Epstein Drangel LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productspharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders

Publications

History of USPTO decisions and trademark events.

31 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

04/19/2025

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

03/29/2025

INPC

INVALIDATION PROCESSED

03/29/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

01/11/2025

C71T

CANCELLED SECTION 71

05/10/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/24/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/16/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/29/2018

FIMP

FINAL DISPOSITION PROCESSED

01/29/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/24/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

10/24/2017

CHPB

POST PUBLICATION AMENDMENT - ENTERED

09/27/2017

APET

ASSIGNED TO PETITION STAFF

09/26/2017

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

09/05/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/08/2017

PUBO

PUBLISHED FOR OPPOSITION

08/08/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/19/2017

RFNT

REFUSAL PROCESSED BY IB

07/01/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/29/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/29/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/29/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/29/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/29/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/09/2017

RFRR

REFUSAL PROCESSED BY MPU

06/09/2017

MAFR

APPLICATION FILING RECEIPT MAILED

05/30/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/27/2017

CNRT

NON-FINAL ACTION WRITTEN

05/26/2017

DOCK

ASSIGNED TO EXAMINER

05/25/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/25/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/18/2017

Continuous trademark protection

Get notified about every new filing that threatens MAVANCLAD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.